EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 299 filers reported holding EXELIXIS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,520,000 | -11.8% | 50,000 | -28.6% | 0.29% | -40.5% |
| Q2 2017 | $1,724,000 | +44.5% | 70,000 | -12.5% | 0.48% | +8.6% |
| Q4 2016 | $1,193,000 | -7.1% | 80,000 | -75.1% | 0.44% | -38.2% |
| Q1 2016 | $1,284,000 | -81.2% | 320,897 | -73.4% | 0.72% | -78.0% |
| Q4 2015 | $6,812,000 | -35.4% | 1,207,726 | -35.8% | 3.26% | -46.6% |
| Q3 2015 | $10,547,000 | +1146.7% | 1,880,004 | +471.4% | 6.11% | +756.4% |
| Q1 2015 | $846,000 | – | 329,000 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |